Rheinmetall's €78 Billion Order Book Meets a €1.7 Billion Cash Gap
Published on 11/07/2026 at 16:52 | Editorial boerse-global.de
Two broker downgrades landed on Rheinmetall this week, and neither was really about demand. Bernstein cut the defence group to "Market-Perform" from "Outperform" and trimmed its price target to €1,000 from €1,200, while Oddo BHF moved to "Neutral" from "Outperform" and slashed its target to €1,200 from €1,670. Shares slipped 1.4% on Friday. The trigger was the company's own guidance reset, confirmed on Thursday: revenue for full-year 2026 is now seen at around €13.2 billion, down from a previous range of €13.7 billion to €14.2 billion, with the operating margin trimmed to roughly 18.5% from about 19%.
Management pinned the revision on expected delays to the Bundeswehr's Arminius programme and later lot acceptances for artillery ammunition. Order intake, advance payments and revenue contributions tied to Arminius are being pushed into 2027, and Rheinmetall also flagged slippage in newer ventures, including its collaboration with Destinus.
Growth Is Not the Problem
The nine-month figures published alongside the cut make that clear. Revenue for the first three quarters of 2026 reached €8.4 billion, up 38% year on year, while operating profit jumped 69% to €1.34 billion — a 16.0% operating margin. Artillery ammunition deliveries for Ukraine and air-defence demand were among the drivers.
What the income statement cannot show is the cash. At the end of September, Rheinmetall's order backlog stood at €78 billion, with 70% of it booked as firm orders. Over the same nine months, cumulative operating free cash flow came in at roughly minus €1.7 billion. The company has the future business; it must first fund it.
Should investors sell immediately? Or is it worth buying Rheinmetall?
The third quarter alone produced negative operating free cash flow of €82 million, and an advance payment of about €150 million arrived in October — a reminder of how much the timing of customer money matters. Rheinmetall still expects positive operating free cash flow for 2026, but capital expenditure is likely to exceed €1 billion, so hitting that target requires a substantial inflow over the remainder of the year. The company has, however, abandoned its previous cash conversion target of more than 40%.
Papperger's Personal Signal
Chief executive Armin Papperger bought more Rheinmetall shares yesterday, extending a purchase already on the record. It is a vote of confidence from the top, though for investors the operative question is whether growth can be financed from the business itself. The bull case rests on execution: if orders are worked off more predictably and customer payments collected reliably, revenue growth and funding needs should converge.
The bear case is a matter of calendar. Delays to the Boxer-based Arminius programme and to acceptance tests for artillery ammunition now stretch into 2027, lengthening the period in which Rheinmetall must carry capacity and production costs. German price reviews on the Arminius contract are a particular sticking point — press reports suggest approval is not expected before February 2027, and without that contract the company is likely to fall short of its targeted order volume by year-end.
Against that, the lowered guidance pairs high expansion spending with lower expected revenue than previously planned. A further slip in major signings or acceptances would keep the backlog tied up in capital while investment needs persist; even strong profit growth would offer only limited relief under those conditions.
Rheinmetall at a turning point? This analysis reveals what investors need to know now.
What to Watch
The next confirmed date on the financial calendar is a capital markets day in Hamburg on 27 November 2026, where investors will be listening for concrete detail on payment timing, investment plans and progress on the delayed projects. Further out, a decision on the XM30 programme is expected in 2027.
For now, the near-term verdict hinges on converting the order book into deliveries and cash. If Rheinmetall improves its cash inflow, the recovery case gains weight. If the delays lengthen, the financing question moves to centre stage.
Ad
Rheinmetall Stock: New Analysis - 7 November
Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
